USA Today: How and why coronavirus makes you sick
UC expert explains the mechanics of how people develop COVID-19
USA Today turned to Dr. Carl Fichtenbaum of the UC Division of Infectious Diseases as the lone medical source for a story explaining how the coronavirus spreads from person to person and physically impacts people who develop COVID-19.
Illustration from USA Today showing how the coronavirus infects people. Photo credit/Kevin Necessary/Cincinnati Enquirer
Dr. Fichtenbaum told USA Today the virus is spread when an infected person expels tiny droplets from the mouth, throat or lungs, usually during a cough or sneeze.
“Viruses need something else’s machinery to help generate them,” Fichtenbaum says. “They’re what we call a parasite.”
Fichtenbaum said the reason some people with COVID-19 lose their sense of smell is because the virus somehow interferes with the olfactory nerve, which transmits sensory data to the brain and is responsible for the sense of smell.
Read the article here.
Featured image at top Dr. Carl Fichtenbaum/Photo credit/Colleen Kelley/UC Creative Services + Brand
Find the latest details related to coronavirus disease 2019 (covid-19) on the Centers for Disease Control and Prevention (CDC) website, and follow UC's latest information with regard to the virus.
Related Stories
High Court offers protections for therapy speech
April 5, 2026
Jennifer Bard, a professor in the Donald P. Klekamp College of Law and the UC Department of Internal Medicine, spoke with journalists about the US Supreme Court ruling granting first amendment protections for speech offered during therapy sessions.
UC names Suzanne Judd, PhD, as inaugural director of new Center for Public Health
April 2, 2026
Following an extensive national search, the University of Cincinnati College of Medicine has appointed Suzanne E. Judd, PhD, as the inaugural director of its newly established Center for Public Health. Judd, a renowned epidemiologist and interdisciplinary scholar, will lead the center’s mission to transform community health through innovative research, education and strategic advocacy.
Could GLP-1s help curb the opioid crisis?
April 1, 2026
The University of Cincinnati's John Winhusen was featured in a Rolling Stone article discussing the potential for GLP-1s to treat substance abuse disorders.